SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-087947
Filing Date
2024-07-30
Accepted
2024-07-30 16:52:07
Documents
13
Period of Report
2024-07-26
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20240726.htm   iXBRL 8-K 49714
2 EX-99.1 tcon-ex99_1.htm EX-99.1 12886
3 GRAPHIC img65184791_0.jpg GRAPHIC 23452
  Complete submission text file 0000950170-24-087947.txt   210327

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcon-20240726.xsd EX-101.SCH 23907
16 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20240726_htm.xml XML 4548
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 241158335
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)